Vical

  www.vical.com
  www.vical.com

Vical Reviews

4 Reviews
2.7
4 Reviews

Recommend to a friend
Approve of CEO
Vical President, CEO, and Director Vijay B. Samant
Vijay B. Samant
3 Ratings
  1.  

    great learning experience

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee in San Diego, CA
    Former Employee - Anonymous Employee in San Diego, CA

    I worked at Vical full-time (more than 3 years)

    Pros

    great central location close to freeways

    Cons

    manufacturing in the same building

    No opinion of CEO

Vical Interviews

Interview Experience

Interview Experience

100%
0%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Administrative Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Application Details

    I applied through other source – interviewed at Vical in April 2009.

    Interview Details

    Very nice pleasant people

    Negotiation Details
    They gave me what I asked for
    Accepted Offer
    Positive Experience
    Average Interview

Vical Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.vical.com
Headquarters San Diego, CA
Size 50 to 149 Employees
Founded 1987
Type Company - Public (VICL)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

Vical counts DNA as its main ally in tackling disease. The biopharmaceutical company researches and develops vaccines based on its DNA delivery technology, which uses portions of the genetic code of a pathogen to induce an immune response. Vical has a number of drug candidates in its pipeline that it is developing independently and through corporate and government collaborations. Its pipeline is focused on infectious disease, cancer immunotherapies, and cardiovascular disease. Vical's lead candidate, being independently-developed, is Allovectin-7, an immunotherapy for... More

Work at Vical? Share Your Experiences

Vical

 
Click to Rate
or